The Use of Positron Emission Tomography (PET) in the Staging/Evaluation, Treatment, and Follow-Up of Patients With Lung Cancer: A Critical Review
- 1 December 2008
- journal article
- review article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 72 (5) , 1298-1306
Abstract
No abstract availableThis publication has 49 references indexed in Scilit:
- Evaluation of the combined effects of target size, respiratory motion and background activity on 3D and 4D PET/CT imagesPhysics in Medicine & Biology, 2008
- Primary Tumor Standardized Uptake Value (SUVmax) Measured on Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is of Prognostic Value for Survival in Non-small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging ProjectJournal of Thoracic Oncology, 2008
- PET Versus PET/CT Dual-Modality Imaging in Evaluation of Lung CancerRadiologic Clinics of North America, 2007
- Oncologic PET/CT: current status and controversiesEuropean Radiology Supplements, 2005
- Visual and Semiquantitative Analyses for F-18 Fluorodeoxyglucose PET Scanning in Pulmonary Nodules 1 cm to 3 cm in SizeThe Annals of Thoracic Surgery, 2005
- Imaging hypoxia and angiogenesis in tumorsRadiologic Clinics of North America, 2005
- Test Performance of Positron Emission Tomography and Computed Tomography for Mediastinal Staging in Patients with Non–Small-Cell Lung CancerAnnals of Internal Medicine, 2003
- Noninvasive Staging of Non-small Cell Lung Cancer*Chest, 2003
- Accuracy of Positron Emission Tomography for Diagnosis of Pulmonary Nodules and Mass LesionsJAMA, 2001
- Metastases from Non-Small Cell Lung Cancer: Mediastinal Staging in the 1990s—Meta-analytic Comparison Of PET and CTRadiology, 1999